Research indicates that rapid absolute lymphocyte count expansion and higher baseline levels significantly predict improved survival and response rates in non-Hodgkin lymphoma patients treated with axicabtagene ciloleucel.
Most Recent Articles
Early Relapse Predicts Poor Survival and Treatment Response in nMTCL
Patients with aggressive T-cell lymphoma who relapse within 12 months face significantly worse survival outcomes but may benefit more from novel targeted therapies than standard chemotherapy.
Targeted Inhibition of Aneurysm Expansion and Vascular Calcification via Oxidation-Sensitive Polymer Delivery
Article Impact Level: HIGH Data Quality: STRONG Summary of Science Advances Dr. Wanling Liu et al. Points Researchers engineered an oxidation-sensitive polymer shell to encapsulate ultrasmall Prussian blue nanoparticles that...
Genomic Identification of ZmpB as a Determinant of Cardiac Damage in Pneumonia
Researchers have identified the ZmpB enzyme in Streptococcus pneumoniae as a key driver of myocardial invasion and subsequent heart failure in pneumonia patients.
Hemodynamic Correlations of Internal Carotid and Vertebral Arteries at High Altitude
A high-altitude study demonstrates that increased perfusion in the internal carotid and vertebral arteries correlates significantly with headache intensity and acute mountain sickness progression.